文献速递主动脉疾病

八旬及以上患者接受开窗和/或分支支架主动脉腔内修复术后早期及随访死亡率的系统评价

Systematic Review on Early and Follow-up Mortality Rate in Octogenarians Treated With a Fenestrated and/or Branched Endovascular Aortic Repair.
PubMed 文献 · J Endovasc Ther · 2023-06-21

本项系统评价与Meta分析纳入截至2022年8月30日的文献,最终纳入6项回顾性研究、共7410例接受开窗和/或分支腔内主动脉修复(F/BEVAR)的复杂主动脉瘤患者,其中1499例(20.2%)年龄≥80岁。八旬及以上患者30天死亡率估计为6%,年轻患者为2%,两组差异未达统计学显著(OR 1.21,95%CI 0.61-1.81;p=0.0.11;I²=36.01%);1年生存率各研究报告不一致,5年生存率八旬及以上患者更低。作者认为老年患者需进行患者选择,并需进一步研究患者风险分层。

要点

  • 八旬及以上患者30天死亡率估计为6%,年轻患者为2%,OR 1.21(95%CI 0.61-1.81;p=0.0.11;I²=36.01%),差异未达统计学显著。
  • 技术成功两组相似(OR -0.83;95%CI -1.74-0.07,p<0.0.001;I²=95.8%)。
  • 因数据缺失,生存率采用叙述性汇总:5年生存率3项研究报告八旬及以上患者更低(26.9%-42% vs 61%-71%)。

核心结论

  • 八旬及以上患者接受F/BEVAR的30天死亡率更高,文献报告其1年和5年生存率更低。
  • 作者认为对高龄患者必须进行患者选择。
  • 作者提出需进一步研究,尤其是患者风险分层,以评估F/BEVAR在老年患者中的结局。

研究设计与样本

  • 本项Meta分析已在PROSPERO预注册(CRD42022348659),并遵循PRISMA 2020声明。
  • 检索Ovid平台的MEDLINE、Embase和CENTRAL数据库英文文献,截至2022年8月30日。
  • 纳入2000-2022年、样本量≥5例、报告八旬及以上与非八旬及以上患者F/BEVAR后30天死亡率及1年和5年生存率的随机对照试验和观察性研究。
  • 采用ROBINS-I工具评估偏倚风险。
  • 初检获得3263篇文献,最终纳入6项回顾性研究,共7410例患者接受F/BEVAR,其中1499例(20.2%)年龄≥80岁(男性75.5%,259/343)。

主要发现

  • 八旬及以上患者30天死亡率估计为6%,年轻患者为2%;年龄≥80岁患者30天死亡率显著更高(OR 1.21,95%CI 0.61-1.81;p=0.0.11;I²=36.01%)。
  • 技术成功两组相似(OR -0.83;95%CI -1.74-0.07,p<0.0.001;I²=95.8%)。
  • 2项研究报告两组1年生存率差异有统计学意义,八旬及以上患者死亡率更高(82.5%-90% vs 89.5%-93%)。
  • 3项研究报告两组1年生存率相似(87.1%-95% vs 88%-89.5%)。
  • 5年时3项研究报告八旬及以上患者生存率显著更低(26.9%-42% vs 61%-71%)。

关键数值与推荐

  • 主要结局为30天死亡率,次要结局为八旬及以上与非八旬及以上患者的1年和5年生存率。
  • 结局以比值比(OR)及95%置信区间(CI)汇总;结局缺失时采用叙述性呈现。
  • 八旬及以上患者30天死亡率6% vs 年轻患者2%(OR 1.21,95%CI 0.61-1.81;p=0.0.11;I²=36.01%)。
  • 技术成功OR -0.83(95%CI -1.74-0.07,p<0.0.001;I²=95.8%)。

临床怎么用

  • 作者认为对高龄患者必须进行患者选择。
  • 作者提出需进一步研究,尤其是患者风险分层,以评估F/BEVAR在老年患者中的结局。

局限性

  • 最终纳入的6项研究均为回顾性研究。
  • 生存率数据缺失,故1年和5年生存率采用叙述性汇总而非Meta分析。
  • 原文指出需要进一步研究,尤其是患者风险分层,以评估F/BEVAR在老年患者中的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Advanced age has been related to conflicting outcomes after fenestrated/branched endovascular aortic aneurysm repair (F/BEVAR). The aim of this meta-analysis is to compare 30-day mortality, technical success, and 1-year and 5-year survival in octogenarians and non-octogenarians who underwent F/BEVAR for complex aortic aneurysms. MATERIALS AND METHODS: This meta-analysis was pre-registered to PROSPERO (CRD42022348659). The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 statement was followed. A search of the English literature, via Ovid, using MEDLINE, Embase, and CENTRAL databases, until August 30, 2022, was executed. Randomized Control Trials and observational studies (2000-2022), with ≥5 patients, reporting on 30-day mortality and 1-year and 5-year survival rates among octogenarians and non-octogenarians after F/BEVAR were eligible. The Risk Of Bias In Non-Randomized Studies of Interventions (ROBINS-I) tool was applied to assess the risk of bias. The primary outcome was 30-day mortality and secondary was 1-year and 5-year survival in octogenarians and non-octogenarians. The outcomes were summarized as odds ratio (OR) with 95% confidence intervals (CIs). A narrative presentation was selected in case of missing outcomes. RESULTS: The initial research isolated 3263 articles; 6 retrospective studies were finally included. A total of 7410 patients were managed with F/BEVAR; 1499 patients (20.2%) were ≥80 years old (75.5% males, 259/343). The estimated 30-day mortality was 6% among octogenarians vs 2% in younger patients, with a significantly higher 30-day mortality for patients ≥80 years old (OR 1.21, 95% CI 0.61-1.81; p=0.0.11; Ι2=36.01%). Technical success was similar between the groups (OR -0.83; 95% CI -1.74-0.07, p<0.0.001; Ι2=95.8%). Regarding survival, a narrative approach was decided due to missing data. Two studies reported a statistically significant difference in 1-year survival between groups, with higher mortality in octogenarians (82.5%-90% vs 89.5%-93%), while 3 reported a similar 1-year survival rate in both groups (87.1%-95% vs 88%-89.5%). At 5 years, 3 studies reported a statistically significant lower survival for octogenarians (26.9%-42% vs 61%-71%). CONCLUSIONS: Octogenarians treated with F/BEVAR presented higher 30-day mortality while a lower survival rate at 1 and 5 years was reported in the literature. Patient selection is thus mandatory among older patients. Further studies, especially on patient risk stratification, are needed to estimate the F/BEVAR outcomes on elder patients.Clinical ImpactAge may be a factor of increased early and long-term mortality within patients managed for aortic aneurysms. In this analysis, patients over 80 years old were compared to their younger counterparts when managed with fenestrated or branched endovascular aortic repair (F/BEVAR) . The analysis showed that early mortality was acceptable for octogenrains but significantly higher when compared to patients younger than 80 years. One-year survival rates are controversial. At 5-year follow-up, octogenarians present lower survival but data to provide metanalysis are lacking. Patient selection and risk stratification are mandatory in older candidates for F/BEVAR.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Nana P, Spanos K, Brotis A, et al. Systematic Review on Early and Follow-up Mortality Rate in Octogenarians Treated With a Fenestrated and/or Branched Endovascular Aortic Repair. J Endovasc Ther. 2023. PMID: 37341255. doi:10.1177/15266028231182798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。